Highlights
NASDAQ: AKTX       Akari Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
2.04   +0.04 (2.00%)  2.00 - 2.09  136,800

Overview

 
Avg Volume (4 weeks):291,752
4 Weeks Range:1.60 - 2.58
4 Weeks Price Volatility (%):
44.90%
52 Weeks Range:0.87 - 3.35
52 Weeks Price Volatility (%):
47.18%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. The firm earns majority of its revenues from United Kingdom. It operates mainly in United States and United Kingdom.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4779  3343  551  179 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GE 6.57-0.21 
 NLY 6.16-0.18 
 SPY 304.32+1.35 
 BAC 24.12-0.74 
 ADAP 11.07+6.21 
 MRO 5.34-0.36 
 F 5.71-0.14 
 XLF 23.41-0.27 
 SQQQ 9.43-0.40 
 NERV 3.71-9.76 
Partners & Brokers